These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35428782)

  • 1. Feasibility of circulating tumor DNA analysis in dogs with naturally occurring malignant and benign splenic lesions.
    Favaro PF; Stewart SD; McDonald BR; Cawley J; Contente-Cuomo T; Wong S; Hendricks WPD; Trent JM; Khanna C; Murtaza M
    Sci Rep; 2022 Apr; 12(1):6337. PubMed ID: 35428782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.
    Wong S; Ehrhart EJ; Stewart S; Zismann V; Cawley J; Halperin R; Briones N; Richter K; Sivaprakasam K; Perdigones N; Contente-Cuomo T; Facista S; Trent JM; Murtaza M; Khanna C; Hendricks WPD
    PLoS One; 2022; 17(7):e0264986. PubMed ID: 35867969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
    Davies O; Taylor AJ
    Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions.
    Meazzi S; Martini V; Marconato L; Aralla M; Licenziato L; Olimpo M; Roccabianca P; Sabattini S; Ubiali A; Zaccone R; Aresu L
    Vet Q; 2024 Dec; 44(1):1-7. PubMed ID: 39224020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
    Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
    BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
    Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
    Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved predictability is needed for calculators used to preoperatively determine the etiology of splenic masses in dogs: an external validation study of the HeLP score and T-STAT.
    Hillier TN; Grimes JA; Wallace ML; Sutherland BJ; Schmiedt CW
    J Am Vet Med Assoc; 2024 Jul; 262(7):917-923. PubMed ID: 38626799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
    Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
    Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can CT texture analysis parameters be used as imaging biomarkers for prediction of malignancy in canine splenic tumors?
    Choi BK; Park S; Lee G; Chang D; Jeon S; Choi J
    Vet Radiol Ultrasound; 2023 Mar; 64(2):224-232. PubMed ID: 36285434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
    Cani AK; Dolce EM; Darga EP; Hu K; Liu CJ; Pierce J; Bradbury K; Kilgour E; Aung K; Schiavon G; Carroll D; Carr TH; Klinowska T; Lindemann J; Marshall G; Rowlands V; Harrington EA; Barrett JC; Sathiyayogan N; Morrow C; Sero V; Armstrong AC; Baird R; Hamilton E; Im SA; Jhaveri K; Patel MR; Dive C; Tomlins SA; Udager AM; Hayes DF; Paoletti C
    Mol Oncol; 2022 May; 16(10):1969-1985. PubMed ID: 34866317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
    Smith CG; Moser T; Mouliere F; Field-Rayner J; Eldridge M; Riediger AL; Chandrananda D; Heider K; Wan JCM; Warren AY; Morris J; Hudecova I; Cooper WN; Mitchell TJ; Gale D; Ruiz-Valdepenas A; Klatte T; Ursprung S; Sala E; Riddick ACP; Aho TF; Armitage JN; Perakis S; Pichler M; Seles M; Wcislo G; Welsh SJ; Matakidou A; Eisen T; Massie CE; Rosenfeld N; Heitzer E; Stewart GD
    Genome Med; 2020 Feb; 12(1):23. PubMed ID: 32111235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.
    Arisi MF; Dotan E; Fernandez SV
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    Borgatti A; Winter AL; Stuebner K; Scott R; Ober CP; Anderson KL; Feeney DA; Vallera DA; Koopmeiners JS; Modiano JF; Froelich J
    PLoS One; 2017; 12(2):e0172651. PubMed ID: 28222142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
    Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
    BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.
    van den Ende T; van der Pol Y; Creemers A; Moldovan N; Boers D; van Berge Henegouwen MI; Hulshof MC; Cillessen SA; van Grieken NC; Pegtel DM; Derks S; Bijlsma MF; Mouliere F; van Laarhoven HW
    J Pathol; 2023 Nov; 261(3):286-297. PubMed ID: 37615198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
    Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG
    Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal dynamics of circulating tumor DNA during immune checkpoint blockade therapy for melanoma.
    Takai E; Omata W; Totoki Y; Nakamura H; Shiba S; Takahashi A; Namikawa K; Mori T; Yamazaki N; Shibata T; Yachida S
    Cancer Sci; 2021 Nov; 112(11):4748-4757. PubMed ID: 34477284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of serum microRNAs with differential expression between dogs with splenic masses and healthy dogs with histologically normal spleens.
    Grimes JA; Robinson KR; Bullington AM; Schmiedt JM
    Am J Vet Res; 2021 Aug; 82(8):659-666. PubMed ID: 34296940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast harmonic ultrasonography of splenic masses and associated liver nodules in dogs.
    Ivancić M; Long F; Seiler GS
    J Am Vet Med Assoc; 2009 Jan; 234(1):88-94. PubMed ID: 19119970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.